Thomas Koed Doktor

1.8k citations

33 papers · 1.1k indexed · h-index 15

Aging top 5%
Genetics top 5%
- Neurogenetic and Muscular Disorders Research 9
Molecular Biology top 10%
- RNA Research and Splicing 20
- RNA modifications and cancer 14
- RNA and protein synthesis mechanisms 9
- RNA regulation and disease 3
- DNA Repair Mechanisms 2
- RNA Interference and Gene Delivery 2
Immunology
Clinical Biochemistry top 10%
Cardiology and Cardiovascular Medicine
- Viral Infections and Immunology Research 3

Co-authors: Brage Storstein Andresen Gitte Hoffmann Bruun Henriette S. Andersen Kinji Ohno Akio Masuda Adrian R. Krainer Lisbeth Dahl Schroeder Anders Etzerodt
Cited by: Aging Genetics Molecular Biology
Journals: Nature (1 paper)Nucleic Acids Research (5 papers)The Journal of Experimental Medicine (1 paper)
Partner nations: Denmark United States Switzerland

In The Last Decade

Thomas Koed Doktor

31 papers receiving 1.1k citations

Peers

Countries citing papers authored by Thomas Koed Doktor

Since Specialization

Citations

This map shows the geographic impact of Thomas Koed Doktor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Koed Doktor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Koed Doktor more than expected).

Fields of papers citing papers by Thomas Koed Doktor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Koed Doktor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Koed Doktor. The network helps show where Thomas Koed Doktor may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas Koed Doktor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Koed Doktor Line = papers co-authored together Thomas Koed Doktor links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	All exons are not created equal—exon vulnerability determines the effect of exonic mutations on splicing Nucleic Acids Research ·Lise Lolle Holm,Thomas Koed Doktor,Katharina Kirkegaard Flugt,Ulrika Simone Spangsberg Petersen,Rikke Agnete Petersen,Brage Storstein Andresen	2024	8
2	Protein kinase CK2 sustains de novo fatty acid synthesis by regulating the expression of SCD-1 in human renal cancer cells Cancer Cell International ·Bárbara Guerra,Kristina Jurčić,Rachelle van der Poel,Samantha L. Cousineau,Thomas Koed Doktor,Laura M. Buchwald,Scott E. Roffey,Caroline A. Lindegaard,Arturo González Ferrer,Aarif Siddiqui,Laszlo Gyenis,Brage Storstein Andresen,David W. Litchfield	2024	0
3	Genome-wide epigenetic and mRNA-expression profiling followed by CRISPR/Cas9-mediated gene-disruptions corroborate the MIR141/MIR200C-ZEB1/ZEB2-FGFR1 axis in acquired EMT-associated EGFR TKI-resistance in NSCLC cells Translational Lung Cancer Research ·Johan Vad‐Nielsen,Nicklas Heine Staunstrup,Magnus Lindkvist Kjeldsen,Nina Dybdal,Guillaume Flandin,Claudia De Stradis,Tina Fuglsang Daugaard,Trine Vilsbøll-Larsen,Christoffer Trier Maansson,Thomas Koed Doktor,Boe Sandahl Sørensen,Anders Lade Nielsen	2023	9
4	Regulating PCCA gene expression by modulation of pseudoexon splicing patterns to rescue enzyme activity in propionic acidemia Molecular Therapy — Nucleic Acids ·Ulrika Simone Spangsberg Petersen,Maja Dembić,Ainhoa Martínez‐Pizarro,Eva Richard,Lise Lolle Holm,Jesper F. Havelund,Thomas Koed Doktor,Martin R. Larsen,Nils J. Færgeman,Lourdes R. Desviat,Brage Storstein Andresen	2023	7
5	Antisense Oligonucleotide Rescue of Deep-Intronic Variants Activating Pseudoexons in the 6-Pyruvoyl-Tetrahydropterin Synthase Gene Nucleic Acid Therapeutics ·Ainhoa Martínez‐Pizarro,Fátima Leal,Lise Lolle Holm,Thomas Koed Doktor,Ulrika Simone Spangsberg Petersen,María Bueno,Beat Thöny,Belén Pérez,Brage Storstein Andresen,Lourdes R. Desviat	2022	11
6	VEGFA-targeting miR-agshRNAs combine efficacy with specificity and safety for retinal gene therapy Molecular Therapy — Nucleic Acids ·Sidsel Alsing,Thomas Koed Doktor,Anne Louise Askou,Emilie Grarup Jensen,Ulvi Ahmadov,Lasse S. Kristensen,Brage Storstein Andresen,Lars Aagaard,Thomas J. Corydon	2022	13
7	DeepCLIP: predicting the effect of mutations on protein–RNA binding with deep learning Nucleic Acids Research ·Alexander G. B. Grønning,Thomas Koed Doktor,Simon J. Larsen,Ulrika Simone Spangsberg Petersen,Lise Lolle Holm,Gitte Hoffmann Bruun,Michael Birkerod Hansen,Anne-Mette Hartung,Jan Baumbach,Brage Storstein Andresen	2020	63
8	Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer The Journal of Experimental Medicine ·Anders Etzerodt,Morgane Moulin,Thomas Koed Doktor,Marcello Delfini,Noushin Mossadegh‐Keller,Marc Bajénoff,Michael H. Sieweke,Søren K. Moestrup,Nathalie Auphan‐Anezin,Toby Lawrence	2020	208
9	Down-regulation of CK2α correlates with decreased expression levels of DNA replication minichromosome maintenance protein complex (MCM) genes Scientific Reports ·Susanne Schaefer,Thomas Koed Doktor,Sabrina B. Frederiksen,Kathleen Chea,Mirka Hlavacova,Gitte Hoffmann Bruun,Maj Rabjerg,Brage Storstein Andresen,Isabel Domínguez,Bárbara Guerra	2019	7
10	Next generation sequencing of RNA reveals novel targets of resveratrol with possible implications for Canavan disease Molecular Genetics and Metabolism ·Maja Dembić,Henriette S. Andersen,Jean Bastin,Thomas Koed Doktor,Thomas J. Corydon,Jörn Oliver Sass,Alexandra Lopes Costa,Fatima Djouadi,Brage Storstein Andresen	2018	14
11	DFI-seq identification of environment-specific gene expression in uropathogenic Escherichia coli BMC Microbiology ·Michelle Madelung,Tina Kronborg,Thomas Koed Doktor,Carsten Struve,Karen A. Krogfelt,Jakob Møller‐Jensen	2017	5
12	RNA-sequencing of a mouse-model of spinal muscular atrophy reveals tissue-wide changes in splicing of U12-dependent introns Nucleic Acids Research ·Thomas Koed Doktor,Yimin Hua,Henriette S. Andersen,Sabrina Brøner,Ying Hsiu Liu,Anna Więckowska,Maja Dembić,Gitte Hoffmann Bruun,Adrian R. Krainer,Brage Storstein Andresen	2016	82
13	Global identification of hnRNP A1 binding sites for SSO-based splicing modulation BMC Biology ·Gitte Hoffmann Bruun,Thomas Koed Doktor,Jonas Borch-Jensen,Akio Masuda,Adrian R. Krainer,Kinji Ohno,Brage Storstein Andresen	2016	56
14	Absence of an Intron Splicing Silencer in Porcine Smn1 Intron 7 Confers Immunity to the Exon Skipping Mutation in Human SMN2 PLoS ONE ·Thomas Koed Doktor,Lisbeth Dahl Schrøder,Henriette S. Andersen,Sabrina Brøner,Anna Kitewska,Charlotte Brandt Sørensen,Brage Storstein Andresen	2014	5
15	A synonymous polymorphic variation in ACADM exon 11 affects splicing efficiency and may affect fatty acid oxidation Molecular Genetics and Metabolism ·Gitte Hoffmann Bruun,Thomas Koed Doktor,Brage Storstein Andresen	2013	20
16	The PAH c.30C>G synonymous variation (p.G10G) creates a common exonic splicing silencer Molecular Genetics and Metabolism ·SF Dobrowolski,Henriette S. Andersen,Thomas Koed Doktor,Brage Storstein Andresen	2010	1
17	The deep intronic c.903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria Human Mutation ·Katerina Homolova,Petra Zavadáková,Thomas Koed Doktor,Lisbeth Dahl Schroeder,Viktor Kožich,Brage Storstein Andresen	2010	45
18	SMN2 exon 7 splicing is inhibited by binding of hnRNP A1 to a common ESS motif that spans the 3′ splice site Human Mutation ·Thomas Koed Doktor,Lisbeth Dahl Schroeder,Anne Vested,Johan Palmfeldt,Henriette S. Andersen,Niels Gregersen,Brage Storstein Andresen	2010	36
19	The phenylalanine hydroxylase c.30C>G synonymous variation (p.G10G) creates a common exonic splicing silencer Molecular Genetics and Metabolism ·Steven F. Dobrowolski,Henriette S. Andersen,Thomas Koed Doktor,Brage Storstein Andresen	2010	18
20	Seemingly Neutral Polymorphic Variants May Confer Immunity to Splicing-Inactivating Mutations: A Synonymous SNP in Exon 5 of MCAD Protects from Deleterious Mutations in a Flanking Exonic Splicing Enhancer The American Journal of Human Genetics ·Karsten Nielsen,Suzette Sørensen,Luca Cartegni,Thomas J. Corydon,Thomas Koed Doktor,Lisbeth Dahl Schroeder,Line S. Reinert,Orly Elpeleg,Adrian R. Krainer,Niels Gregersen,Jørgen Kjems,Brage Storstein Andresen	2007	117

About Thomas Koed Doktor

Thomas Koed Doktor is a scholar working on Genetics, Aging and Molecular Biology, having authored 33 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA Research and Splicing (20 papers), RNA modifications and cancer (14 papers), Neurogenetic and Muscular Disorders Research (9 papers), RNA and protein synthesis mechanisms (9 papers), RNA regulation and disease (3 papers), Viral Infections and Immunology Research (3 papers), DNA Repair Mechanisms (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Aging (69 citations), Genetics (165 citations) and Molecular Biology (862 citations). Thomas Koed Doktor has collaborated with scholars based in Denmark, United States and Switzerland. Frequent co-authors include Brage Storstein Andresen, Gitte Hoffmann Bruun, Henriette S. Andersen, Kinji Ohno, Akio Masuda, Adrian R. Krainer, Lisbeth Dahl Schroeder, Anders Etzerodt, Mikako Ito and Marcello Delfini. Their work appears in journals such as Nature, Nucleic Acids Research and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact